Royalty Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Royalty Pharma has a total shareholder equity of $10.1B and total debt of $6.1B, which brings its debt-to-equity ratio to 60.8%. Its total assets and total liabilities are $16.4B and $6.3B respectively. Royalty Pharma's EBIT is $1.5B making its interest coverage ratio 13. It has cash and short-term investments of $495.3M.
Key information
60.8%
Debt to equity ratio
US$6.14b
Debt
Interest coverage ratio | 13x |
Cash | US$495.31m |
Equity | US$10.08b |
Total liabilities | US$6.30b |
Total assets | US$16.38b |
Recent financial health updates
No updates
Recent updates
Royalty Pharma's (NASDAQ:RPRX) Earnings Are Weaker Than They Seem
Feb 22Royalty Pharma: Solid Operational Performance
Feb 19Royalty Pharma (NASDAQ:RPRX) Will Pay A Larger Dividend Than Last Year At $0.21
Jan 31Royalty Pharma: One Of The Best Names In Pharmaceuticals
Jan 22Royalty Pharma plc's (NASDAQ:RPRX) Share Price Matching Investor Opinion
Dec 26Royalty Pharma's (NASDAQ:RPRX) Upcoming Dividend Will Be Larger Than Last Year's
May 12Royalty Pharma (NASDAQ:RPRX) Is Increasing Its Dividend To $0.20
Apr 20Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be Increased To $0.20
Jan 16Royalty Pharma to co-fund development of schizophrenia drug with Merck
Oct 12Royalty Pharma: Strategic Royalty Interest Acquisition To Drive Significant Growth
Aug 18Royalty Pharma declares $0.19 dividend
Jul 15Royalty Pharma: Unique Diversification, Bear Market Performer
May 26The Price Is Right For Royalty Pharma plc (NASDAQ:RPRX)
Apr 25Royalty Pharma Offers A Unique Long-Term Investment Opportunity
Mar 01Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be Increased To US$0.19
Jan 25Royalty Pharma (NASDAQ:RPRX) Will Pay A Larger Dividend Than Last Year At US$0.19
Jan 11Royalty Pharma: A Pharma-Like Company Without The Same Risks
Dec 27Financial Position Analysis
Short Term Liabilities: RPRX's short term assets ($1.3B) exceed its short term liabilities ($161.4M).
Long Term Liabilities: RPRX's short term assets ($1.3B) do not cover its long term liabilities ($6.1B).
Debt to Equity History and Analysis
Debt Level: RPRX's net debt to equity ratio (55.9%) is considered high.
Reducing Debt: RPRX's debt to equity ratio has reduced from 143.2% to 60.8% over the past 5 years.
Debt Coverage: RPRX's debt is well covered by operating cash flow (48.7%).
Interest Coverage: RPRX's interest payments on its debt are well covered by EBIT (13x coverage).